Archrock, Inc. (AROC)
NYSEEnergyOil & Gas Equipment & ServicesSnapshot 2026-11-04
NYSEEnergyOil & Gas Equipment & ServicesSnapshot 2026-11-04
Research Workspace
Put AROC beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Oil & Gas Equipment & Services is in recovery. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Contract operations gross margin near 72%: Comparison needs review.
View ThesisRevenue growth is slowing — up about 4% over the past year and decelerating.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens strong on capital allocation, market reaction to earnings.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskAROC's growth capex plan must keep compounding to justify the price. The company reaffirmed its 2026 adjusted EBITDA target. It also outlined a multi-year growth capex plan. The latest quarter beat estimates by 6.5%. AROC trades at 14x earnings versus a 22x peer median. This discount reflects modest growth expectations in the price. Contract operations gross margin is under pressure. The thesis comparison is not yet verified. Peer multiples imply a price roughly in line with where it trades. The thesis is on watch. This read is provisional.
Trailing returns as of 2026-11-04. AROC is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 7 analysts currently covering AROC (as of Nov 2026).
Based on 3 Wall Street analysts offering 12-month price targets for AROC in the last 4 months.
Continue this research
Compare AROC with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| AROC Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 13 valuation methods, at three horizons. As of 2026-11-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Oil & Gas Equipment & Services — fair value, gap to price, and forward P/E.
Compare the value case
Put AROC next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Grow profitable platform via growth capex and long-term contracts
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-11-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $28.61
The last 12 months of price, then the range of analyst 12-month targets from today’s $28.61.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Reaffirms EBITDA and details growth capex plan.

Advances: Maintain and improve operating income and margins
EPS beat supports margin and operating income objectives.

Advances: Grow revenue and profitable platform
Contract win and dividend increase support revenue growth.

Advances: Grow revenue and profitable platform
Compression business growth aligns with revenue objectives.

Price target increase suggests positive market sentiment.